Ondřej Gojiš
- Cancer Research top 10%
- Breast Cancer Treatment Studies 4
- Molecular Biology top 10%
- Epigenetics and DNA Methylation 2
- RNA modifications and cancer 2
- Receptor Mechanisms and Signaling 2
- Genetics top 10%
- Estrogen and related hormone effects 5
- Oncology top 10%
- HER2/EGFR in Cancer Research 6
-
- Brain Metastases and Treatment 2
-
- Monoclonal and Polyclonal Antibodies Research 2
- Co-authors
- Carlo PalmieriJason S. CarrollSimak AliIan O. EllisCarlos CaldasH. Raza AliAndrew R. GreenAndrew E. Teschendorff
- Partner nations
- United KingdomCzechiaItaly
In The Last Decade
Ondřej Gojiš
18 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 96
- Cancer Research 298
- Molecular Biology 1.2k
- Genetics 296
- Oncology 279
- Immunology 175
Countries citing papers authored by Ondřej Gojiš
This map shows the geographic impact of Ondřej Gojiš's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ondřej Gojiš with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ondřej Gojiš more than expected).
Fields of papers citing papers by Ondřej Gojiš
This network shows the impact of papers produced by Ondřej Gojiš. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ondřej Gojiš. The network helps show where Ondřej Gojiš may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ondřej Gojiš, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | [The results of five years follow-up prospective study of vaginal prolapse repaired by prolift total mesh surgery or sacrospinous fixation]. | 2019 | 3 |
| 2 | 2015 | 14 | |
| 3 | 2015 | 4 | |
| 4 | 2013 | 25 | |
| 5 | 2013 | 4 | |
| 6 | 2013 | 5 | |
| 7 | Differential oestrogen receptor binding is associated with clinical outcome in breast cancerbreakdown → | 2012 | 1304 |
| 8 | 2012 | 12 | |
| 9 | 2012 | 35 | |
| 10 | 2012 | 34 | |
| 11 | 2011 | 13 | |
| 12 | 2011 | 16 | |
| 13 | 2011 | 32 | |
| 14 | 2010 | 2 | |
| 15 | 2010 | 3 | |
| 16 | 2009 | 31 | |
| 17 | 2009 | 1 | |
| 18 | 2009 | 41 |
About Ondřej Gojiš
Ondřej Gojiš is a scholar working on Oncology, Cancer Research and Obstetrics and Gynecology, having authored 18 papers that have together received 1.6k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (6 papers), Estrogen and related hormone effects (5 papers), Breast Cancer Treatment Studies (4 papers), Brain Metastases and Treatment (2 papers), Epigenetics and DNA Methylation (2 papers), RNA modifications and cancer (2 papers), Receptor Mechanisms and Signaling (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). The work is most often cited by research in Cancer Research (298 citations), Molecular Biology (1.2k citations) and Genetics (296 citations). Ondřej Gojiš has collaborated with scholars based in United Kingdom, Czechia and Italy. Frequent co-authors include Carlo Palmieri, Jason S. Carroll, Simak Ali, Ian O. Ellis, Carlos Caldas, H. Raza Ali, Andrew R. Green, Andrew E. Teschendorff, Gordon D. Brown and Mark Dunning. Their work appears in journals such as Nature, The Lancet and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.